BMI≥50 kg/m²患者减重手术前桥接干预的系统综述与荟萃分析
该系统综述与荟萃分析纳入13项研究共550例BMI≥50 kg/m²患者,评估减重手术前桥接干预的效果与安全性。桥接干预包括一期腹腔镜袖状胃切除术(LSG)、胃内球囊(IGB)和液体低热量饮食(LLCD)。桥接干预后BMI平均降低12.8 kg/m²(95%CI 9.49-16.1,P<0.0001),LSG和LLCD均安全有效,IGB未显示显著减重。
要点
- BMI≥50 kg/m²患者桥接干预后BMI平均降低12.8 kg/m²。
- 一期LSG减重效果显著,BMI降低15.2 kg/m²。
- LLCD亦安全有效,BMI降低9.8 kg/m²,IGB无显著减重。
核心结论
- 一期LSG和LLCD均是安全且合适的桥接干预,可在BMI大于50 kg/m²患者减重手术前实现有效减重。
研究设计与样本
- 系统综述与荟萃分析,检索MEDLINE、EMBASE、Web of Science和Scopus从建库至2018年9月,纳入13项研究共550例患者,平均基线BMI为61.26 kg/m²。
主要发现
- 桥接干预后BMI平均降低12.8 kg/m²(MD 12.8,95%CI 9.49-16.1,P<0.0001)。
- LSG后BMI降低15.2 kg/m²(95%CI 12.9-17.5,P<0.0001)。
- 术前LLCD后BMI降低9.8 kg/m²(95%CI 9.82-15.4,P=0.0006)。
- IGB在减重手术前未显示显著减重。
- 2型糖尿病、高血压和睡眠呼吸暂停分别有62.8%、74.6%和74.6%的患者缓解或改善。
临床怎么用
- 对于BMI≥50 kg/m²患者,可考虑一期LSG或LLCD作为减重手术前的桥接干预以实现有效减重。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Bariatric surgery on patients with body mass index (BMI) ≥ 50 kg/m2, historically known as superobesity, is technically challenging and carries a higher risk of complications. Bridging interventions have been introduced for weight loss before bariatric surgery in this population. This systematic review and meta-analysis aims to assess the efficacy and safety of bridging interventions before bariatric surgery in patients with BMI ≥ 50 kg/m2. METHODS: MEDLINE, EMBASE, Web of Science, and Scopus were searched from database inception to September 2018. Studies were eligible for inclusion if they conducted any bridging intervention for weight loss in patients with BMI greater than 50 kg/m2 prior to bariatric surgery. Primary outcome was the change in BMI before and after bridging intervention. Secondary outcomes included comorbidity status after bridging interventions and resulting complications. Pooled mean differences (MD) were calculated using random effects meta-analysis. RESULTS: 13 studies including 550 patients met inclusion criteria (mean baseline BMI of 61.26 kg/m2). Bridging interventions included first-step laparoscopic sleeve gastrectomy (LSG), intragastric balloon (IGB), and liquid low-calorie diet program (LLCD). There was a reduction of BMI by 12.8 kg/m2 after a bridging intervention (MD 12.8, 95% CI 9.49-16.1, P < 0.0001). Specifically, LSG demonstrated a BMI reduction of 15.2 kg/m2 (95% CI 12.9-17.5, P < 0.0001) and preoperative LLCD by 9.8 kg/m2 (95% CI 9.82-15.4, P = 0.0006). IGB did not demonstrate significant weight loss prior to bariatric surgery. There was remission or improvement of type 2 diabetes, hypertension, and sleep apnea in 62.8%, 74.6%, and 74.6% of patients, respectively. CONCLUSIONS: First-step LSG and LLCD are both safe and appropriate bridging interventions which can allow for effective weight loss prior to bariatric surgery in patients with BMI greater than 50 kg/m2.
引用
- Lee Y, Dang JT, Switzer N, et al. Bridging interventions before bariatric surgery in patients with BMI ≥ 50 kg/m2: a systematic review and meta-analysis. Surg Endosc. 2019. PMID: 31399947. doi:10.1007/s00464-019-07027-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。